The EU Commission, aiming to ensure smooth and predictable implementation of the AI Act, is preparing a comprehensive set of guidelines for 2026. These will offer practical directions on high-risk classifications, transparency, reporting obligations, quality requirements, responsibilities, and more. Special focus will be on simplifying research exemptions and clarifying legal overlaps, particularly for product development in medicines and medical devices. The Commission will also provide templates and direct support channels for stakeholders.